Health Land Corporation
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Health Land Corporation
No Result
View All Result
Home Health Care

Average cost of a family health insurance plan now nearly $27,000

by
October 22, 2025
in Health Care
0
Average cost of a family health insurance plan now nearly $27,000

The cost of employer-sponsored health insurance rose for the third year in a row in 2025, approaching an average of almost $27,000 for a family plan, according to an annual survey from KFF released Wednesday. 

Family premiums are up 6 percent, or $1,408, from last year, more than double the rate of inflation and similar to the 7 percent increase recorded in each of the previous two years. 

On average, workers contributed $6,850 annually to the cost of family coverage, with employers paying the rest. 

The annual survey of more than 1,800 small and large employers offers a snapshot of workplace-sponsored health insurance across the country. Nearly half the U.S. population — about 154 million people under age 65 — receive health care coverage through their job. 

The large increase in premiums is being driven primarily by increased spending on health care. According to the survey, employers are singling out drug prices as a factor contributing to higher premiums in recent years. 

Significant shares of firms also cited the prevalence of chronic disease, higher utilization of services and hospital prices.  

Among firms with more than 200 employees, more than a third said prescription drug prices contributed “a great deal” to higher premiums in recent years. Chief among them are the popular GLP-1 drugs, which include he weight-loss treatments Wegovy and Zepbound. 

Among the biggest firms — those with at least 5,000 workers — 43 percent said they cover GLP-1 drugs for weight loss in their largest plan, up from 28 percent in 2024. 

“There is a quiet alarm bell going off. With GLP-1s, increases in hospital prices, tariffs and other factors, we expect employer premiums to rise more sharply next year,” KFF president and CEO Drew Altman said in a statement. 

But the cost of health insurance is more than just premiums. The average deductible for an individual plan is now almost $1,900, compared to $1,773 last year. On average, workers at small firms face deductibles almost $1,000 higher than workers at larger firms. 

More than half of covered workers at small firms now face a deductible of at least $2,000, and more than a third face an average single deductible of at least $3,000, the survey found. 

KFF said it expects deductibles and other forms of cost-sharing may climb as companies look to push more costs of medical care onto employees.

“Employers have nothing new in their arsenal that can address most of the drivers of their cost increases, and that could well result in an increase in deductibles and other forms of employee cost sharing again, a strategy that neither employers nor employees like but companies resort to in a pinch to hold down premium increases,” Altman said.  

Previous Post

Fetterman believes Thune ‘sincere’ about ACA talks after shutdown

Next Post

Trump pollster: ObamaCare subsidy extension key for GOP ahead of midterms

Next Post
Trump pollster: ObamaCare subsidy extension key for GOP ahead of midterms

Trump pollster: ObamaCare subsidy extension key for GOP ahead of midterms

  • Trending
  • Comments
  • Latest
How to untangle ethics of psychedelics for therapeutic care

How to untangle ethics of psychedelics for therapeutic care

May 2, 2024
Novel therapy reduces depression in family caregivers

Novel therapy reduces depression in family caregivers

June 4, 2022
Planned Parenthood to spend $40m to boost Biden, Democrats ahead of November

Planned Parenthood to spend $40m to boost Biden, Democrats ahead of November

June 24, 2024
The Benefits of Joining a Fitness Group

The Benefits of Joining a Fitness Group

April 8, 2024
Biden administration suspends funding for scientist at center of COVID lab leak theory

Biden administration suspends funding for scientist at center of COVID lab leak theory

0
Novel teamwork, promising results for glioblastoma treatment

Novel teamwork, promising results for glioblastoma treatment

0
‘Harvard Thinking’: Facing death with dignity

‘Harvard Thinking’: Facing death with dignity

0
Asking the internet about birth control

Asking the internet about birth control

0
FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

March 10, 2026
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

March 9, 2026
Tracking mysteries of loss of Y chromosome, cancer

Tracking mysteries of loss of Y chromosome, cancer

March 9, 2026
How realistic is ‘The Pitt’?

How realistic is ‘The Pitt’?

March 9, 2026

Enter Your Information Below To Receive Latest News And Articles

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time

    Recent News

    FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

    FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

    March 10, 2026
    Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

    Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

    March 9, 2026
    Tracking mysteries of loss of Y chromosome, cancer

    Tracking mysteries of loss of Y chromosome, cancer

    March 9, 2026
    How realistic is ‘The Pitt’?

    How realistic is ‘The Pitt’?

    March 9, 2026

    Recent News

    FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

    FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

    March 10, 2026
    Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

    Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

    March 9, 2026

    Popular News

    • FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism
    • Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

    About Health Land Corporation

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2024 Healthlandcorporation.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2024 Healthlandcorporation.com. All Rights Reserved.